Nanda Iryuza

437 posts

Nanda Iryuza banner
Nanda Iryuza

Nanda Iryuza

@Iryuza

Interventional Cardiologist at National Cardiovascular Center Harapan Kita 🇮🇩

Jakarta Capital Region Katılım Nisan 2010
561 Takip Edilen235 Takipçiler
Nanda Iryuza retweetledi
Dr. Filippo Cademartiri
Dr. Filippo Cademartiri@FCademartiri·
🫀📉 Can more intensive LDL-lowering improve CT-FFR in stable chest pain? This new JACC study evaluates whether intensive lipid-lowering therapy (statin + ezetimibe) alters CT-derived fractional flow reserve (FFR-CT) — a noninvasive marker of lesion-specific ischemia — in patients with stable chest pain and coronary atherosclerosis. 🔍 Study essentials Patients with stable angina and coronary plaque on CT angiography were managed with aggressive lipid-lowering using statins plus ezetimibe, targeting substantial LDL-C reduction. FFR-CT was measured at baseline and on follow-up to assess functional changes in coronary physiology attributable to therapy. 📈 Key message The core focus — integrating structural and functional imaging — points to a key concept: lipid-lowering can potentially improve lesion physiology, not just plaque burden. By using FFR-CT (a validated surrogate for invasive FFR), the authors are examining whether aggressive LDL-reduction actually shifts physiological indices toward less ischemia. 🧠 Why this matters Lipid-lowering benefits have traditionally been shown at the event level (MI, death). Structural plaque regression with statins/ezetimibe is documented in IVUS and CT studies. But fewer data exist on functional improvement in coronary blood flow with therapy. Linking lipid therapy to improved FFR-CT suggests that LDL-lowering may not only slow plaque progression but also improve coronary physiology — a potential mechanistic bridge to clinical benefit. 📌 Bottom line: Intensive lipid-lowering might influence not only plaque morphology but lesion-specific ischemia as assessed noninvasively, expanding our understanding of how therapies translate into physiological improvement.
Dr. Filippo Cademartiri tweet media
English
3
18
59
20.7K
Mamas A. Mamas
Mamas A. Mamas@mmamas1973·
Wonderful to host @Iryuza our interventional fellow from Indonesia who has been with us for the past year for a PCI / TAVI fellowship . It is his last week with us and has been a joy to have him here. Looking forward to a long collaboration with many more fellows
Mamas A. Mamas tweet media
English
5
5
99
4.4K
Nanda Iryuza
Nanda Iryuza@Iryuza·
@mmamas1973 Thank you very much Prof, for having me here. I am very grateful for the opportunity and the experience.
English
1
0
6
69
Nanda Iryuza
Nanda Iryuza@Iryuza·
Great honor to have my mentor, Prof. @mmamas1973 in Jakarta for ISICAM! Proud to do a successful live case together at the National Cardiovascular Center Harapan Kita. Educational, inspiring, and memorable. Hope you enjoyed the event! @ISIC_Official @aninkasaboe
Nanda Iryuza tweet mediaNanda Iryuza tweet mediaNanda Iryuza tweet mediaNanda Iryuza tweet media
English
2
5
9
1.6K
Nanda Iryuza retweetledi
Mamas A. Mamas
Mamas A. Mamas@mmamas1973·
Great to do opening live case at #ISICAM with medina 1.1.1 lms disease and diffuse lad disease. Oct and physiology guided provisional hybrid approach with prox lad stent into lms, then cutting balloon guided seloution dcb in mid lad with @Iryuza @aninkasaboe @uziyahya46 @mirvatalasnag
Mamas A. Mamas tweet mediaMamas A. Mamas tweet mediaMamas A. Mamas tweet mediaMamas A. Mamas tweet media
English
3
10
68
10.3K
Nanda Iryuza retweetledi
ISIC
ISIC@ISIC_Official·
💡 See Beyond the Vessel — Master Coronary Physiology! Join our hands-on Workshop on Physiology and learn how to guide treatment & optimize outcomes through evidence-based physiology and imaging integration. 🗓 Wed, 5 Nov 2025 | 🕐 13.00–17.00 WIB 📍 Jawa Room, Shangri-La Jakarta 🔗 Register now at isicam.id #ISICAM2025 #StayOnTrack @uziyahya46 @Iryuza
ISIC tweet media
English
0
1
1
444
Nanda Iryuza retweetledi
ISIC
ISIC@ISIC_Official·
🔥 Hidden Dangers, Visible Impact! High-risk plaques may stay silent — until it’s too late. Discover how advanced imaging transforms early detection into life-saving action. 📅 Fri, 7 Nov 2025 | 🕚 11.00–12.00 WIB 📍 Ballroom A, Shangri-La Jakarta 🚀 Don’t miss your next breakthrough — register now at isicam.id #ISICAM2025 #StayOnTrack @uziyahya46 @mmamas1973 @RoccoVergallo @IndahSP_MD et al.
ISIC tweet media
English
0
5
5
1K
Nanda Iryuza retweetledi
Ashley Miller
Ashley Miller@icmteaching·
Pinned: Cardiovascular Physiology Hub Discovering physiology together: untangling the concepts most often misunderstood at the bedside. Foundations – Starling’s law as servo-control x.com/icmteaching/st… – Cardiac output & Anderson’s model x.com/icmteaching/st… – Preload x.com/icmteaching/st… – Making sense of acid–base x.com/icmteaching/st… – Afterload & systemic vascular resistance x.com/icmteaching/st… Concepts in flow & pressure – Critical closing pressure & waterfalls (series)  • Part 1 x.com/icmteaching/st…  • Part 2 x.com/icmteaching/st… – High-output heart failure x.com/icmteaching/st… – Why is CVP in the MAP equation? x.com/icmteaching/st… – Tissue perfusion x.com/icmteaching/st… Frameworks & applied physiology – Shock: pump vs pipes framework x.com/icmteaching/st… – Interface model of shock x.com/icmteaching/st… – Cardiac output monitors x.com/icmteaching/st… – Sepsis does not cause hypovolaemia x.com/icmteaching/st… Why RCTs fail (3-part series) – Part 1: Consensus, thresholds & physiology x.com/icmteaching/st… – Part 2: Heterogeneity vs colliders x.com/icmteaching/st… – Part 3: Beyond colliders x.com/icmteaching/st… I’ll keep adding here as new threads drop.
Ashley Miller@icmteaching

1/ Most people think the heart drives circulation. But what if that’s backwards? Anderson’s model flips the whole idea of cardiac output on its head — and it changes how you think about fluid, flow, and failure. 🧵👇 #physiology #FOAMed #MedTwitter #criticalCare #cardiacOutput

English
3
58
171
34K
Nanda Iryuza retweetledi
Murmur MD
Murmur MD@Murmur_MD·
Planning a PBMV? Don’t start without this! Dr. Walsh shares a concise, practical prep guide easy to bookmark and refer back to. #CardioTwitter #CardioX #CathLab
English
2
18
92
9.1K
Nanda Iryuza retweetledi
Abdulla A. Damluji, MD, PhD
Abdulla A. Damluji, MD, PhD@DrDamluji·
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy: @CircAHA 🥸 Rx of nonculprit lesions in STEMI or NSTEMI: @GreggWStone 😱 Summary 👇👇👇
Abdulla A. Damluji, MD, PhD tweet media
English
2
34
126
13.6K
Nanda Iryuza retweetledi
CardiovascularCorner
CardiovascularCorner@TrackYourHeart·
TIMI Flow: A Key Indicator of Coronary Perfusion TIMI (Thrombolysis in Myocardial Infarction) flow grading is a crucial angiographic tool to assess blood flow in coronary arteries, particularly after an intervention like PCI. 🔹 TIMI 0 (No Flow) – Complete occlusion; no antegrade flow beyond the blockage. 🔹 TIMI 1 (Penetration without Perfusion) – Minimal flow beyond the occlusion but without adequate distal vessel opacification. 🔹 TIMI 2 (Partial Flow) – Delayed but complete filling of the distal vessel; flow is slower than normal. 🔹 TIMI 3 (Normal Flow) – Full, brisk perfusion with normal distal vessel filling, comparable to a non-diseased artery. TIMI 3 flow is the gold standard for successful reperfusion in PCI, improving outcomes in STEMI and other coronary syndromes. #Cardiology #TIMIFlow #CathLab
English
0
95
333
18.4K
Nanda Iryuza retweetledi
SCAI
SCAI@SCAI·
Bifurcation Cases With OCT and Coronary CT-OCTOBER and P4 Trials x.com/i/broadcasts/1…
English
0
15
47
7.6K
Nanda Iryuza retweetledi
CoreAalst
CoreAalst@CoreAalst·
🚨Dr. Bernard De Bruyne’s @BernardBruyne Physiology Masterclass episode is now live! 🚨 Learn how coronary physiology is helping us understand plaque rupture. 🫀💥 What stood out to you in this episode? Let us know in the comments!👇 Want to watch the previous Physiology Masterclasses? Find them all here: coreaalstplatform.com/coreaalst/modu… @EmanueleBarba13 @ColletCarlos @SimoneBiscaglia @jeroen_sonck @CardioAalst @OLVZaalst #Cardiology #PhysiologyMasterclass #FocalDisease #DiffuseDisease
English
1
12
28
2.2K